2025-10-09 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided data. The report is structured with numbers first, followed by analysis.

**Report on Teladoc Health Inc. (TDOC)**

**0. Introduction**

This report analyzes Teladoc Health Inc. (TDOC), a telehealth company, based on recent stock performance, financial data, analyst opinions, and news.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TDOC
*   **Company:** Teladoc Health Inc.
*   **Description:** Teladoc Health Inc. delivers virtual healthcare services, connecting patients with doctors via phone and video.
*   **TDOC Cumulative Return:** -56.27%
*   **VOO Cumulative Return:** 100.65%
*   **Absolute Divergence (TDOC - VOO):** -156.92%
*   **Relative Divergence:** 1.3

**Analysis of Divergence:** TDOC has significantly underperformed the S&P 500 (VOO) with a cumulative return difference of -156.92%. The Relative Divergence of 1.3 suggests that TDOC's performance is near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD      | Alpha     | Beta     | Cap(B)   |
|------------|----------|----------|-----------|----------|----------|
| 2015-2017  | 77.0%    | 70.4%    | 51.0%     | -0.1     | 6.2      |
| 2016-2018  | 101.0%   | 69.4%    | 86.0%     | -0.1     | 8.8      |
| 2017-2019  | 141.0%   | 73.8%    | 118.0%    | 0.3      | 14.8     |
| 2018-2020  | 105.0%   | 80.9%    | 81.0%     | 0.3      | 35.3     |
| 2019-2021  | -78.0%   | 80.9%    | -125.0%   | 0.3      | 16.2     |
| 2020-2022  | -252.0%  | 85.9%    | -251.0%   | -0.9     | 4.2      |
| 2021-2023  | -315.0%  | 85.9%    | -316.0%   | -1.8     | 3.8      |
| 2022-2024  | -93.0%   | 85.9%    | -113.0%   | -1.9     | 1.6      |
| 2023-2025  | -27.0%   | 81.6%    | -91.0%    | -0.8     | 1.6      |

**Analysis of Alpha/Beta:**

*   **CAGR:**  Shows periods of strong growth early on, followed by significant declines in recent years.
*   **MDD (Maximum Drawdown):** Consistently high, indicating substantial risk and volatility.
*   **Alpha:**  Positive alpha in earlier periods suggests outperformance relative to the market.  However, recent years show strongly negative alpha, indicating significant underperformance.
*   **Beta:** Beta fluctuates and has trended negative.
*   **Cap(B):** Market capitalization has decreased to 1.6B

**2. Recent Stock Price Movement**

*   **Current Price:** $9.09
*   **Last Market Data:** {'price': 9.09, 'previousClose': 8.37, 'change': 8.6}
*   **5-Day Moving Average:** 8.704
*   **20-Day Moving Average:** 8.1555
*   **60-Day Moving Average:** 7.7769

**Analysis of Stock Price:** The current price is above the 5, 20, and 60-day moving averages, suggesting a short-term upward trend.  The `change` of 8.6 indicates a significant one-day price increase, indicating an upside potential.

**3. Market Risk Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment)
*   **RSI (Relative Strength Index):** 59.18
*   **PPO (Percentage Price Oscillator):** 0.8971
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (110 shares - Very Safe - MRI:0.90)
*   **Recent Relative Divergence Change (20-day):** 1.0 (+) (Short-term Increase)
*   **Expected Return (%):** -7222.6

**Analysis of Indicators:**

*   **MRI:**  The MRI of 0.9 suggests that the investment is in the "Medium Investment" risk category.
*   **RSI:**  An RSI of 59.18 suggests the stock is approaching overbought territory, but not yet overbought.
*   **PPO:**  A positive PPO indicates a short-term upward trend relative to a longer-term trend.
*   **Hybrid Signal:** The Hybrid Signal recommends buying 100% of cash, suggesting a positive outlook despite the risks.
*   **Recent Relative Divergence Change:** The positive change indicates recent outperformance compared to its historical relationship with the S&P 500.
*   **Expected Return:** The extremely negative expected return indicates a very poor outlook for long-term returns relative to the S&P 500.

**4. Recent News & Significant Events**

*   **[2025-10-08]** Fusion Health Continues Successful EHR Rollout at Tennessee Department of Correction Amid Strong Company Growth
*   **[2025-10-08]** Why Is Teladoc (TDOC) Stock Soaring Today
*   **[2025-10-08]** Online Marketplace Stocks Q2 In Review: Teladoc (NYSE:TDOC) Vs Peers
*   **[2025-10-07]** Teladoc and Uber Stocks Trade Down, What You Need To Know
*   **[2025-10-07]** Teladoc Health (TDOC): Assessing Valuation After Recent Share Price Swings and Analyst Narratives
*   **[2025-10-07]** Is Progyny (PGNY) Stock Undervalued Right Now?

**News Analysis:** Recent news is mixed. While there are positive headlines about Teladoc's stock "soaring" and EHR rollout, there are also articles discussing stock price declines and valuation assessments. This suggests potential volatility and uncertainty surrounding the stock.

**4-2. Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Rating:** 2.64 (Hold)
*   **Opinions:** 20
*   **Target Price:**
    *   Average: $9.18
    *   High: $12.00
    *   Low: $7.00
*   **Recent Rating Changes:** Not Available

**Analyst Opinion Analysis:**  The consensus rating of "Hold" suggests that analysts are generally neutral on the stock. The average target price ($9.18) is slightly above the current price ($9.09), indicating a small potential upside.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-07-30 | -0.19  | 0.63 B$    |
| 2025-05-01 | -0.53  | 0.63 B$    |
| 2024-10-31 | -0.19  | 0.64 B$    |
| 2024-08-01 | -4.92  | 0.64 B$    |
| 2025-07-30 | -4.92  | 0.64 B$    |

**Earnings Analysis:** The company has consistently reported negative EPS (Earnings Per Share). Revenue has been relatively stable but is not translating into profitability. This is a significant concern.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $0.63B    | 69.85%       |
| 2025-03-31 | $0.63B    | 68.73%       |
| 2024-12-31 | $0.64B    | 70.50%       |
| 2024-09-30 | $0.64B    | 71.94%       |
| 2024-06-30 | $0.64B    | 70.73%       |

**Capital and Profitability:**

| Quarter    | Equity     | ROE        |
|------------|------------|------------|
| 2025-06-30 | $1.42B    | -2.30%    |
| 2025-03-31 | $1.43B    | -6.52%    |
| 2024-12-31 | $1.49B    | -3.25%    |
| 2024-09-30 | $1.51B    | -2.21%    |
| 2024-06-30 | $1.50B    | -55.77%   |

**Financial Analysis:**

*   **Revenue:**  Revenue is relatively consistent across the quarters.
*   **Profit Margin:** Profit margins are high, consistently around 70%, which is a positive sign.
*   **Equity:** Equity has been decreasing slightly over the quarters.
*   **ROE (Return on Equity):** ROE is consistently negative, indicating that the company is not generating profits from its equity.

**7. Overall Summary**

Teladoc Health Inc. (TDOC) presents a mixed picture.

*   **Negative Factors:**
    *   Significant underperformance compared to the S&P 500.
    *   History of negative EPS and negative ROE.
    *   High Maximum Drawdown indicates high volatility.
    *   Extremely negative expected return raises concerns about long-term investment.
*   **Positive Factors:**
    *   Recent positive stock price movement.
    *   Relatively high profit margins.
    *   Hybrid Signal recommending a buy.
    *   MRI indicating Medium Investment.
*   **Neutral Factors:**
    *   Analyst consensus is "Hold."
    *   Mixed news headlines.

**Conclusion:**

TDOC is a high-risk investment. While there are some positive short-term indicators, the long-term financial performance and historical underperformance compared to the market are significant concerns. Investors should carefully weigh these factors before investing. The recent stock price surge might be a short-term correction, and the underlying financial challenges remain.
